Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Xencor presents data on anti-CD19 and anti-CD40 antibodies

Xencor presents data on anti-CD19 and anti-CD40 antibodies

New data on ZOLINZA (vorinostat) in combination with Bortezomib

New data on ZOLINZA (vorinostat) in combination with Bortezomib

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Lenalidomide safe for elderly patients with chronic lymphocytic leukemia

Novel therapeutic approaches for various forms of thrombocytopenia

Novel therapeutic approaches for various forms of thrombocytopenia

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Incyte's selective Janus kinase inhibitor demonstrates rapid and durable clinical benefits in Myelofibrosis patients

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Researchers focus on phosphoinositide 3-kinase pathway in cancer research

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

Swiss approval for Zevtera in treatment of complicated skin and soft tissue infections

On the trail of a targeted therapy for blood cancer

On the trail of a targeted therapy for blood cancer

Researchers explore issues related to multiple myeloma treatment

Researchers explore issues related to multiple myeloma treatment

No blood needed thanks to non-invasive blood monitoring device

No blood needed thanks to non-invasive blood monitoring device

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Cytopia announces novel anti-cancer drug development collaboration

Cytopia announces novel anti-cancer drug development collaboration

Role of genetic components of dendritic cells could lead to more effective drugs

Role of genetic components of dendritic cells could lead to more effective drugs

Researchers study Rituximab's action on cancer stem cells

Researchers study Rituximab's action on cancer stem cells

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia